Industry Research Reports
Home > Reports > Chemical & Material > Global Fosfomycin Sodium API Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Fosfomycin Sodium API Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-11-08
Pages: 148 Pages
Report ld: 5382855
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Fosfomycin Sodium API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Fosfomycin Sodium API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ercros SA
- Mac-Chem Products (India)
- Sumar Biotech
- Shin Poong Pharm
- NorthEast Pharm
- Harbin Pharmaceutical Group
- Shanxi Dongjin Pharmaceutical
- New Asiatic Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity Above 99%
- Purity Below 99%
Segment by Application
- Injection
- Liquid Drops
CHAPTER OUTLINE
Chapter 1: Defines the Fosfomycin Sodium API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Fosfomycin Sodium API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fosfomycin Sodium API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity Above 99%
1.2.3 Purity Below 99%
1.3 Market Segmentation by Application
1.3.1 Global Fosfomycin Sodium API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injection
1.3.3 Liquid Drops
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fosfomycin Sodium API Revenue Estimates and Forecasts 2020-2031
2.2 Global Fosfomycin Sodium API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Fosfomycin Sodium API Sales Estimates and Forecasts 2020-2031
2.4 Global Fosfomycin Sodium API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Fosfomycin Sodium API Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Fosfomycin Sodium API Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Fosfomycin Sodium API Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity Above 99% Market Size by Manufacturers
4.5.2 Purity Below 99% Market Size by Manufacturers
4.6 Global Fosfomycin Sodium API Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Fosfomycin Sodium API Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Fosfomycin Sodium API Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Fosfomycin Sodium API Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Fosfomycin Sodium API Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Fosfomycin Sodium API Sales and Revenue by Type (2020-2031)
7.4 North America Fosfomycin Sodium API Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Fosfomycin Sodium API Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Fosfomycin Sodium API Sales and Revenue by Type (2020-2031)
8.4 Europe Fosfomycin Sodium API Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Fosfomycin Sodium API Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Fosfomycin Sodium API Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Fosfomycin Sodium API Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Fosfomycin Sodium API Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Fosfomycin Sodium API Sales and Revenue by Type (2020-2031)
10.4 Central and South America Fosfomycin Sodium API Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Fosfomycin Sodium API Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Fosfomycin Sodium API Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Fosfomycin Sodium API Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Fosfomycin Sodium API Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Ercros SA
12.1.1 Ercros SA Corporation Information
12.1.2 Ercros SA Business Overview
12.1.3 Ercros SA Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.1.4 Ercros SA Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ercros SA Fosfomycin Sodium API Sales by Product in 2024
12.1.6 Ercros SA Fosfomycin Sodium API Sales by Application in 2024
12.1.7 Ercros SA Fosfomycin Sodium API Sales by Geographic Area in 2024
12.1.8 Ercros SA Fosfomycin Sodium API SWOT Analysis
12.1.9 Ercros SA Recent Developments
12.2 Mac-Chem Products (India)
12.2.1 Mac-Chem Products (India) Corporation Information
12.2.2 Mac-Chem Products (India) Business Overview
12.2.3 Mac-Chem Products (India) Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.2.4 Mac-Chem Products (India) Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Mac-Chem Products (India) Fosfomycin Sodium API Sales by Product in 2024
12.2.6 Mac-Chem Products (India) Fosfomycin Sodium API Sales by Application in 2024
12.2.7 Mac-Chem Products (India) Fosfomycin Sodium API Sales by Geographic Area in 2024
12.2.8 Mac-Chem Products (India) Fosfomycin Sodium API SWOT Analysis
12.2.9 Mac-Chem Products (India) Recent Developments
12.3 Sumar Biotech
12.3.1 Sumar Biotech Corporation Information
12.3.2 Sumar Biotech Business Overview
12.3.3 Sumar Biotech Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.3.4 Sumar Biotech Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Sumar Biotech Fosfomycin Sodium API Sales by Product in 2024
12.3.6 Sumar Biotech Fosfomycin Sodium API Sales by Application in 2024
12.3.7 Sumar Biotech Fosfomycin Sodium API Sales by Geographic Area in 2024
12.3.8 Sumar Biotech Fosfomycin Sodium API SWOT Analysis
12.3.9 Sumar Biotech Recent Developments
12.4 Shin Poong Pharm
12.4.1 Shin Poong Pharm Corporation Information
12.4.2 Shin Poong Pharm Business Overview
12.4.3 Shin Poong Pharm Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.4.4 Shin Poong Pharm Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Shin Poong Pharm Fosfomycin Sodium API Sales by Product in 2024
12.4.6 Shin Poong Pharm Fosfomycin Sodium API Sales by Application in 2024
12.4.7 Shin Poong Pharm Fosfomycin Sodium API Sales by Geographic Area in 2024
12.4.8 Shin Poong Pharm Fosfomycin Sodium API SWOT Analysis
12.4.9 Shin Poong Pharm Recent Developments
12.5 NorthEast Pharm
12.5.1 NorthEast Pharm Corporation Information
12.5.2 NorthEast Pharm Business Overview
12.5.3 NorthEast Pharm Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.5.4 NorthEast Pharm Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 NorthEast Pharm Fosfomycin Sodium API Sales by Product in 2024
12.5.6 NorthEast Pharm Fosfomycin Sodium API Sales by Application in 2024
12.5.7 NorthEast Pharm Fosfomycin Sodium API Sales by Geographic Area in 2024
12.5.8 NorthEast Pharm Fosfomycin Sodium API SWOT Analysis
12.5.9 NorthEast Pharm Recent Developments
12.6 Harbin Pharmaceutical Group
12.6.1 Harbin Pharmaceutical Group Corporation Information
12.6.2 Harbin Pharmaceutical Group Business Overview
12.6.3 Harbin Pharmaceutical Group Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.6.4 Harbin Pharmaceutical Group Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Harbin Pharmaceutical Group Recent Developments
12.7 Shanxi Dongjin Pharmaceutical
12.7.1 Shanxi Dongjin Pharmaceutical Corporation Information
12.7.2 Shanxi Dongjin Pharmaceutical Business Overview
12.7.3 Shanxi Dongjin Pharmaceutical Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.7.4 Shanxi Dongjin Pharmaceutical Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shanxi Dongjin Pharmaceutical Recent Developments
12.8 New Asiatic Pharmaceutical
12.8.1 New Asiatic Pharmaceutical Corporation Information
12.8.2 New Asiatic Pharmaceutical Business Overview
12.8.3 New Asiatic Pharmaceutical Fosfomycin Sodium API Product Models, Descriptions and Specifications
12.8.4 New Asiatic Pharmaceutical Fosfomycin Sodium API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 New Asiatic Pharmaceutical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Fosfomycin Sodium API Industry Chain
13.2 Fosfomycin Sodium API Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Fosfomycin Sodium API Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Fosfomycin Sodium API Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Fosfomycin Sodium API Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Fosfomycin Sodium API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Fosfomycin Sodium API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Fosfomycin Sodium API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Fosfomycin Sodium API Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fosfomycin Sodium API Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Fosfomycin Sodium API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Fosfomycin Sodium API Sales by Region (2020-2025) & (Tons)
Table 8. Global Fosfomycin Sodium API Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Fosfomycin Sodium API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Fosfomycin Sodium API Production by Region (2020-2025) & (Tons)
Table 12. Global Fosfomycin Sodium API Production by Region (2026-2031) & (Tons)
Table 13. Global Fosfomycin Sodium API Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Fosfomycin Sodium API Sales Share by Manufacturers (2020-2025)
Table 15. Global Fosfomycin Sodium API Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Fosfomycin Sodium API Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Fosfomycin Sodium API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fosfomycin Sodium API as of 2024)
Table 19. Global Fosfomycin Sodium API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Fosfomycin Sodium API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Fosfomycin Sodium API Manufacturing Base and Headquarters
Table 22. Global Fosfomycin Sodium API Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Fosfomycin Sodium API Sales by Type (2020-2025) & (Tons)
Table 26. Global Fosfomycin Sodium API Sales by Type (2026-2031) & (Tons)
Table 27. Global Fosfomycin Sodium API Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Fosfomycin Sodium API Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Fosfomycin Sodium API ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Fosfomycin Sodium API Sales by Application (2020-2025) & (Tons)
Table 32. Global Fosfomycin Sodium API Sales by Application (2026-2031) & (Tons)
Table 33. Fosfomycin Sodium API High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Fosfomycin Sodium API Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Fosfomycin Sodium API Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Fosfomycin Sodium API ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Fosfomycin Sodium API Growth Accelerators and Market Barriers
Table 40. North America Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Fosfomycin Sodium API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Fosfomycin Sodium API Growth Accelerators and Market Barriers
Table 43. Europe Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Fosfomycin Sodium API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Fosfomycin Sodium API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Fosfomycin Sodium API Growth Accelerators and Market Barriers
Table 48. Southeast Asia Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Fosfomycin Sodium API Investment Opportunities and Key Challenges
Table 50. Central and South America Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Fosfomycin Sodium API Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Fosfomycin Sodium API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Ercros SA Corporation Information
Table 54. Ercros SA Description and Major Businesses
Table 55. Ercros SA Product Models, Descriptions and Specifications
Table 56. Ercros SA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Ercros SA Sales Value Proportion by Product in 2024
Table 58. Ercros SA Sales Value Proportion by Application in 2024
Table 59. Ercros SA Sales Value Proportion by Geographic Area in 2024
Table 60. Ercros SA Fosfomycin Sodium API SWOT Analysis
Table 61. Ercros SA Recent Developments
Table 62. Mac-Chem Products (India) Corporation Information
Table 63. Mac-Chem Products (India) Description and Major Businesses
Table 64. Mac-Chem Products (India) Product Models, Descriptions and Specifications
Table 65. Mac-Chem Products (India) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Mac-Chem Products (India) Sales Value Proportion by Product in 2024
Table 67. Mac-Chem Products (India) Sales Value Proportion by Application in 2024
Table 68. Mac-Chem Products (India) Sales Value Proportion by Geographic Area in 2024
Table 69. Mac-Chem Products (India) Fosfomycin Sodium API SWOT Analysis
Table 70. Mac-Chem Products (India) Recent Developments
Table 71. Sumar Biotech Corporation Information
Table 72. Sumar Biotech Description and Major Businesses
Table 73. Sumar Biotech Product Models, Descriptions and Specifications
Table 74. Sumar Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Sumar Biotech Sales Value Proportion by Product in 2024
Table 76. Sumar Biotech Sales Value Proportion by Application in 2024
Table 77. Sumar Biotech Sales Value Proportion by Geographic Area in 2024
Table 78. Sumar Biotech Fosfomycin Sodium API SWOT Analysis
Table 79. Sumar Biotech Recent Developments
Table 80. Shin Poong Pharm Corporation Information
Table 81. Shin Poong Pharm Description and Major Businesses
Table 82. Shin Poong Pharm Product Models, Descriptions and Specifications
Table 83. Shin Poong Pharm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Shin Poong Pharm Sales Value Proportion by Product in 2024
Table 85. Shin Poong Pharm Sales Value Proportion by Application in 2024
Table 86. Shin Poong Pharm Sales Value Proportion by Geographic Area in 2024
Table 87. Shin Poong Pharm Fosfomycin Sodium API SWOT Analysis
Table 88. Shin Poong Pharm Recent Developments
Table 89. NorthEast Pharm Corporation Information
Table 90. NorthEast Pharm Description and Major Businesses
Table 91. NorthEast Pharm Product Models, Descriptions and Specifications
Table 92. NorthEast Pharm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. NorthEast Pharm Sales Value Proportion by Product in 2024
Table 94. NorthEast Pharm Sales Value Proportion by Application in 2024
Table 95. NorthEast Pharm Sales Value Proportion by Geographic Area in 2024
Table 96. NorthEast Pharm Fosfomycin Sodium API SWOT Analysis
Table 97. NorthEast Pharm Recent Developments
Table 98. Harbin Pharmaceutical Group Corporation Information
Table 99. Harbin Pharmaceutical Group Description and Major Businesses
Table 100. Harbin Pharmaceutical Group Product Models, Descriptions and Specifications
Table 101. Harbin Pharmaceutical Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Harbin Pharmaceutical Group Recent Developments
Table 103. Shanxi Dongjin Pharmaceutical Corporation Information
Table 104. Shanxi Dongjin Pharmaceutical Description and Major Businesses
Table 105. Shanxi Dongjin Pharmaceutical Product Models, Descriptions and Specifications
Table 106. Shanxi Dongjin Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Shanxi Dongjin Pharmaceutical Recent Developments
Table 108. New Asiatic Pharmaceutical Corporation Information
Table 109. New Asiatic Pharmaceutical Description and Major Businesses
Table 110. New Asiatic Pharmaceutical Product Models, Descriptions and Specifications
Table 111. New Asiatic Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. New Asiatic Pharmaceutical Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Fosfomycin Sodium API Product Picture
Figure 2. Global Fosfomycin Sodium API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity Above 99% Product Picture
Figure 4. Purity Below 99% Product Picture
Figure 5. Global Fosfomycin Sodium API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Injection
Figure 7. Liquid Drops
Figure 8. Fosfomycin Sodium API Report Years Considered
Figure 9. Global Fosfomycin Sodium API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 11. Global Fosfomycin Sodium API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Fosfomycin Sodium API Revenue Market Share by Region (2020-2031)
Figure 13. Global Fosfomycin Sodium API Sales (2020-2031) & (Tons)
Figure 14. Global Fosfomycin Sodium API Sales (CAGR) by Region (2020-2031) (Tons)
Figure 15. Global Fosfomycin Sodium API Sales Market Share by Region (2020-2031)
Figure 16. Global Fosfomycin Sodium API Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 17. Global Fosfomycin Sodium API Production Trend by Region (2020-2031) (Tons)
Figure 18. Global Fosfomycin Sodium API Production Market Share by Region (2020-2031)
Figure 19. Production Capacity Enablers & Constraints
Figure 20. Fosfomycin Sodium API Production Growth Rate in North America (2020-2031) & (Tons)
Figure 21. Fosfomycin Sodium API Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 22. Fosfomycin Sodium API Production Growth Rate in China (2020-2031) & (Tons)
Figure 23. Fosfomycin Sodium API Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 24. Top 5 and Top 10 Manufacturers Fosfomycin Sodium API Sales Volume Market Share in 2024
Figure 25. Global Fosfomycin Sodium API Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Purity Above 99% Revenue Market Share by Manufacturer in 2024
Figure 28. Purity Below 99% Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global Fosfomycin Sodium API Sales Market Share by Type (2020-2031)
Figure 32. Global Fosfomycin Sodium API Revenue Market Share by Type (2020-2031)
Figure 33. Global Fosfomycin Sodium API Sales Market Share by Application (2020-2031)
Figure 34. Global Fosfomycin Sodium API Revenue Market Share by Application (2020-2031)
Figure 35. North America Fosfomycin Sodium API Sales YoY (2020-2031) & (Tons)
Figure 36. North America Fosfomycin Sodium API Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Fosfomycin Sodium API Sales Revenue (US$ Million) in 2024
Figure 38. North America Fosfomycin Sodium API Sales Volume (Tons) by Type (2020- 2031)
Figure 39. North America Fosfomycin Sodium API Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Fosfomycin Sodium API Sales Volume (Tons) by Application (2020-2031)
Figure 41. North America Fosfomycin Sodium API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Fosfomycin Sodium API Sales YoY (2020-2031) & (Tons)
Figure 46. Europe Fosfomycin Sodium API Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Fosfomycin Sodium API Sales Revenue (US$ Million) in 2024
Figure 48. Europe Fosfomycin Sodium API Sales Volume (Tons) by Type (2020-2031)
Figure 49. Europe Fosfomycin Sodium API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Fosfomycin Sodium API Sales Volume (Tons) by Application (2020-2031)
Figure 51. Europe Fosfomycin Sodium API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 53. France Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Fosfomycin Sodium API Sales YoY (2020-2031) & (Tons)
Figure 58. Asia-Pacific Fosfomycin Sodium API Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Fosfomycin Sodium API Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Fosfomycin Sodium API Sales Volume (Tons) by Type (2020- 2031)
Figure 61. Asia-Pacific Fosfomycin Sodium API Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Fosfomycin Sodium API Sales Volume (Tons) by Application (2020-2031)
Figure 63. Asia-Pacific Fosfomycin Sodium API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 68. India Fosfomycin Sodium API Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Fosfomycin Sodium API Sales YoY (2020-2031) & (Tons)
Figure 70. Central and South America Fosfomycin Sodium API Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Fosfomycin Sodium API Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Fosfomycin Sodium API Sales Volume (Tons) by Type (2021-2031)
Figure 73. Central and South America Fosfomycin Sodium API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Fosfomycin Sodium API Sales Volume (Tons) by Application (2020-2031)
Figure 75. Central and South America Fosfomycin Sodium API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Fosfomycin Sodium API Sales YoY (2020-2031) & (Tons)
Figure 79. Middle East and Africa Fosfomycin Sodium API Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Fosfomycin Sodium API Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Fosfomycin Sodium API Sales Volume (Tons) by Type (2021-2031)
Figure 82. South America Fosfomycin Sodium API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Fosfomycin Sodium API Sales Volume (Tons) by Application (2020-2031)
Figure 84. Middle East and Africa Fosfomycin Sodium API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Fosfomycin Sodium API Revenue (2020-2025) & (US$ Million)
Figure 89. Fosfomycin Sodium API Industry Chain Mapping
Figure 90. Regional Fosfomycin Sodium API Manufacturing Base Distribution (%)
Figure 91. Fosfomycin Sodium API Production Process
Figure 92. Regional Fosfomycin Sodium API Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Fosfomycin Sodium API market?
The top companies in the global Fosfomycin Sodium API market are Ercros SA、Mac-Chem Products (India)、Sumar Biotech.
Related Reports
Fosfomycin Sodium API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fosfomycin Sodium API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 127
USD 3950.00
(Single User License)
Global Fosfomycin Sodium API Market Research Report 2026
The global Fosfomycin Sodium API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 129
USD 2900.00
(Single User License)
Global Fosfomycin Sodium API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fosfomycin Sodium API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 79
USD 4250.00
(Single User License)
Fosfomycin Sodium API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fosfomycin Sodium API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 96
USD 3950.00
(Single User License)
Global Fosfomycin Sodium API Market Research Report 2025
The global market for Fosfomycin Sodium API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
Global Fosfomycin Sodium API Market Research Report 2024
The global Fosfomycin Sodium API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 91
USD 2900.00
(Single User License)
Fosfomycin Sodium API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fosfomycin Sodium API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 127
USD 3950.00 (Single User License)Global Fosfomycin Sodium API Market Research Report 2026
The global Fosfomycin Sodium API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 129
USD 2900.00 (Single User License)Global Fosfomycin Sodium API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fosfomycin Sodium API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 79
USD 4250.00 (Single User License)Fosfomycin Sodium API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fosfomycin Sodium API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 96
USD 3950.00 (Single User License)Global Fosfomycin Sodium API Market Research Report 2025
The global market for Fosfomycin Sodium API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 89
USD 2900.00 (Single User License)Global Fosfomycin Sodium API Market Research Report 2024
The global Fosfomycin Sodium API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now